TY - JOUR
T1 - Chinese Stroke Center Alliance
T2 - A national effort to improve healthcare quality for acute stroke and transient ischaemic attack: Rationale, design and preliminary findings
AU - Wang, Yongjun
AU - Li, Zixiao
AU - Wang, Yilong
AU - Zhao, Xingquan
AU - Liu, Liping
AU - Yang, Xin
AU - Wang, Caiyun
AU - Gu, Hongqiu
AU - Zhang, Fuying
AU - Wang, Chunjuan
AU - Xian, Ying
AU - Wang, David Z.
AU - Dong, Qiang
AU - Xu, Anding
AU - Zhao, Jizong
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2018.
PY - 2018/12/1
Y1 - 2018/12/1
N2 - Background In June 2015, the Chinese Stroke Association (CSA) initiated the Chinese Stroke Center Alliance (CSCA) to establish the national hospital-based stroke care quality assessment and improvement platform. This article outlines its objectives, operational structure, patient population, quality improvement (QI) intervention tools, data elements, data collection methodology and current patient and hospital data. Methods The CSCA is a national, hospital-based, multicentre, voluntary, multifaceted intervention and continuous QI initiative. This multifaceted intervention includes stroke centre development, written care protocols, workshops and a monitoring/feedback system of evidence-based performance measures. The data coordinating centre of the CSCA resides at the China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital. Results As of July 2017, 1576 hospitals in China have contributed detailed clinical information to serve as a benchmark for the stroke care quality of 433 264 patients with acute stroke/transient ischaemic attacks (TIA), including 352 572 (81.38%) acute ischaemic stroke, 30 362 (7.01%) TIA, 42 080 (9.71%) spontaneous intracranial haemorrhage, 5505 (1.27%) subarachnoid haemorrhage and 2745 (0.63%) not specified stroke. Conclusion The CSCA programme is designed to establish a continuous national stroke registry and help healthcare providers develop stroke centres and treat patients in a consistent manner in accordance with accepted national guidelines and, ultimately, improve patient outcomes. It supports the CSA mission to reduce stroke burden in China.
AB - Background In June 2015, the Chinese Stroke Association (CSA) initiated the Chinese Stroke Center Alliance (CSCA) to establish the national hospital-based stroke care quality assessment and improvement platform. This article outlines its objectives, operational structure, patient population, quality improvement (QI) intervention tools, data elements, data collection methodology and current patient and hospital data. Methods The CSCA is a national, hospital-based, multicentre, voluntary, multifaceted intervention and continuous QI initiative. This multifaceted intervention includes stroke centre development, written care protocols, workshops and a monitoring/feedback system of evidence-based performance measures. The data coordinating centre of the CSCA resides at the China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital. Results As of July 2017, 1576 hospitals in China have contributed detailed clinical information to serve as a benchmark for the stroke care quality of 433 264 patients with acute stroke/transient ischaemic attacks (TIA), including 352 572 (81.38%) acute ischaemic stroke, 30 362 (7.01%) TIA, 42 080 (9.71%) spontaneous intracranial haemorrhage, 5505 (1.27%) subarachnoid haemorrhage and 2745 (0.63%) not specified stroke. Conclusion The CSCA programme is designed to establish a continuous national stroke registry and help healthcare providers develop stroke centres and treat patients in a consistent manner in accordance with accepted national guidelines and, ultimately, improve patient outcomes. It supports the CSA mission to reduce stroke burden in China.
KW - Chinese stroke center alliance
KW - acute stroke
KW - healthcare quality
KW - transient ischemic attack
UR - http://www.scopus.com/inward/record.url?scp=85053047178&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85053047178&partnerID=8YFLogxK
U2 - 10.1136/svn-2018-000154
DO - 10.1136/svn-2018-000154
M3 - Article
C2 - 30637133
AN - SCOPUS:85053047178
SN - 2059-8688
VL - 3
SP - 256
EP - 262
JO - Stroke and Vascular Neurology
JF - Stroke and Vascular Neurology
IS - 4
ER -